Trinity Biotech and its subsidiaries are currently working on the development of 22 products that fall under the In Vitro Diagnostics markets. GlobalData’s report Trinity Biotech Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are either in the late stage of development or are in an early development stage.
The main research and development focus of Trinity Biotech is on infectious diseases, followed by cardiovascular diseases, hematologic diseases, immune system diseases, nutritional and metabolic diseases and respiratory tract diseases.